×

AM2016 Long Course Part 2 - Newly Described Salivary Gland Tumors


Original release date: March 15, 2016
Access to this course expires on: March 15, 2019
CME/SAM
0.75

Faculty: Alena Skalova, MD, PhD, Charles University in Prague, Czech Republic

Learning Objectives
  1. To recognize the characteristic histologic, immunohistochemical and genetic features of diagnostically challenging and newly described tumor entities in salivary gland pathology; in particular mammary analogue secretory carcinoma (MASC), cribiform cystadenocarcinoma of tongue and other minor salivary glands (CATS), and sclerosing polycystic adenoma (SPA)
  2. To describe the differential diagnosis for those entities, emphasizing the benign and low grade malignant possibilities. Discussion of each entity will include histopathological features, differential diagnosis, utility of ancillary studies, impact on surveillance and management, and insight into molecular pathogenesis.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.

Members: Add To Cart To Get Your Discount - Not A Member? Click Here